Search for: "ALLERGAN, INC., a Delaware corporation"
Results 1 - 17
of 17
Sorted by Relevance
|
Sort by Date
9 Apr 2013, 7:23 am
Sys., et al., holding that a derivative suit against Botox-maker Allergan, Inc. should be dismissed because Allergan had already secured a judgment in its favor in a nearly identical suit in California. [read post]
15 Nov 2014, 9:12 pm
In re Allergan Inc. [read post]
23 Apr 2013, 12:00 pm
On September 1, 2010, following a Department of Justice investigation, Allergan, Inc. [read post]
29 May 2014, 3:44 am
Now Francis Pileggi of Eckert Seamans blogs this news: A proposed new addition and amendments to the Delaware General Corporation Law would limit the impact of a recent Delaware Supreme Court decision in ATP Tours, Inc. v. [read post]
1 Dec 2009, 9:45 am
(patent infringement) 11/19: Allergan Inc., Allergan USA Inc., Allergan Sales, LLC, Endo Pharmaceuticals Solutions Inc., Supernus Pharmaceuticals Inc. v. [read post]
20 Jun 2012, 12:38 pm
The complaints alleged that the board of directors of Allergan Inc. was liable for failing to prevent Allergan from improperly marketing its Botox drug and thereby incurring a massive fine for doing so. [read post]
17 Feb 2010, 8:00 am
(patent infringement) 1/8: Allergan Inc. v. [read post]
18 Jun 2012, 2:00 am
After the federal court dismissed the plaintiffs’ complaint pursuant to FRCP Rule 23.1 with prejudice (In re Allergan, Inc. [read post]
4 Jul 2017, 10:07 am
In this instance, the court found sufficient static material facts to determine whether entering into the voting agreement constituted a breach of fiduciary duty, and distinguished the decision in In re: Allergan, Inc. [read post]
27 Jun 2012, 11:33 am
Allergan, Inc., a Delaware corporation which develops and commercializes specialty pharmaceuticals, biologics, and medical devices, specifically Botox Therapeutic, entered into the settlement after admitting that they illegally promoted off-label uses of their popular drug. [read post]
21 Jul 2021, 12:44 pm
The distributors named in the complaint were McKesson Corporation, Cardinal Health Inc., Amerisource Bergen Drug Corporation, and Rochester Drug Cooperative Inc. [read post]
26 Dec 2017, 5:00 am
Nelson, J.D.For the second time in a week Delaware courts have explained, in the words of former Chancellor Allen, the author of the Caremark decision, why the Caremark claim is “possibly the most difficult theory in corporation law upon which a plaintiff might hope to win a judgment. [read post]
20 Sep 2007, 10:05 pm
New York., D. of Delaware, N.D. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel)… [read post]
10 Feb 2017, 5:54 am
Dugan and Michael Nonaka, Covington & Burling LLP, on Monday, February 6, 2017 Tags: Banks, Conflicts of interest, Dodd-Frank Act, DOL, Donald Trump, Fiduciary duties, Fiduciary rule, Financial advisers, Financial institutions, Financial regulation, FSOC, Securities regulation, Systemic risk Corporate Power is Corporate Purpose II: An Encouragement for Future Consideration from Professors Johnson and Millon Posted by Kobi Kastiel, Co-editor, HLS Forum on Corporate… [read post]
20 Mar 2017, 2:04 pm
[Disclosure: Goldstein & Russell, P.C., whose attorneys contribute to this blog in various capacities, is among the counsel on an amicus brief by Ericsson Inc., Allergan, Inc., and Traxxas L.P. in support of the respondent in this case. [read post]
5 Jul 2008, 11:05 am
: (Intellectual Property Watch), Why compulsory licenses are bad: a look at the sausage making process: (Techdirt) More on ACTA: (LawFont.com) Global - Trade Marks / Domain Names / Brands Brand Finance 500: the annual report on the world’s most valuable brands: (IP finance), Gretchen Olive’s ‘10 steps to an effective domain name policy’: (IPwar’s), ICANN approves GNSO proposals imposing financial penalty on registrars who engage in excessive domain… [read post]
